Suppr超能文献

对交感神经系统的抑制作用与咪达普利和依那普利引起的急性低血压之间无关联。

No relation of the suppressive effect on the sympathetic nervous system to the acute hypotension caused by imidapril and enalapril.

作者信息

Ogiku N, Sumikawa H, Ishida R

机构信息

Pharmacological Research Laboratory, Tanabe Seiyaku Co., Ltd., Saitama, Japan.

出版信息

Jpn J Pharmacol. 1993 Nov;63(3):295-303. doi: 10.1254/jjp.63.295.

Abstract

To investigate the involvement of the sympathoinhibitory effect of imidapril and enalapril in their antihypertensive effect at a clinically reasonable dose, we studied whether some responses induced by the stimulation of the sympathetic nervous system (SNS) were affected by intravenous administration of imidaprilat and enalaprilat in curarized pithed spontaneously hypertensive rats. Imidaprilat and enalaprilat (both at 100 micrograms/kg, i.v.), which are active metabolites of imidapril and enalapril, respectively, suppressed the pressor responses to electrical stimulation (ES) of the spinal cord (T1-L7) and exogenous noradrenaline (NA). The pressor responses to NA were significantly suppressed after either alpha 1- or alpha 2-adrenoceptors were blocked. Furthermore, imidaprilat (100 micrograms/kg, i.v.) suppressed these reduced responses. When the reduced basal blood pressure was restored by vasopressin infusion, imidaprilat and enalaprilat (both at 100 micrograms/kg, i.v.) did not suppress the responses to ES and exogenous alpha-adrenoceptor agonists. They affected neither basal plasma concentrations of NA and adrenaline nor ES-induced increase of these catecholamines. These results suggest that the suppressive effects of imidaprilat and enalaprilat on the pressor responses to ES and alpha-adrenoceptors agonists are apparently observed in pithed SHR because of a reduction of vascular tone and that imidapril and enalapril do not lower the blood pressure through suppressing SNS.

摘要

为了研究依米达普利和依那普利在临床合理剂量下的交感神经抑制作用是否参与其降压效应,我们研究了在箭毒化、脊髓切断的自发性高血压大鼠中,静脉注射依米达普利拉和依那普利拉是否会影响交感神经系统(SNS)刺激所诱导的一些反应。依米达普利拉和依那普利拉(均为100微克/千克,静脉注射)分别是依米达普利和依那普利的活性代谢产物,它们抑制了对脊髓(T1-L7)电刺激(ES)和外源性去甲肾上腺素(NA)的升压反应。在α1或α2肾上腺素受体被阻断后,对NA的升压反应被显著抑制。此外,依米达普利拉(100微克/千克,静脉注射)抑制了这些减弱的反应。当通过输注血管加压素使降低的基础血压恢复时,依米达普利拉和依那普利拉(均为100微克/千克,静脉注射)并未抑制对ES和外源性α肾上腺素受体激动剂的反应。它们既不影响NA和肾上腺素的基础血浆浓度,也不影响ES诱导的这些儿茶酚胺的增加。这些结果表明,在脊髓切断的SHR中,由于血管张力降低,明显观察到依米达普利拉和依那普利拉对ES和α肾上腺素受体激动剂的升压反应有抑制作用,并且依米达普利和依那普利不会通过抑制SNS来降低血压。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验